James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Alphabet Inc: Google Capital Owns a Piece of Care.com Inc, What Now? (GOOG, CRCM)

Alphabet (GOOGL) is broadening its business horizons with Care.com (CRCM), even if it seems like it's treating all these deals like a hobby.

10 Biotech Stocks That Could Erupt Within Months

These biotech stocks have some major, potentially price-changing news lined up between now and the end of September.

Why Mastercard Inc (MA), Royal Bank of Scotland Group PLC (RBS) and Tractor Supply Company (TSCO) Are 3 of Today’s Worst Stocks

Mastercard (MA), Royal Bank of Scotland Group (RBS), Tractor Supply Company (TSCO) just couldn't get on board Thursday's bullish train.

Why Alcoa Inc (AA), Esperion Therapeutics Inc (ESPR) and Southwestern Energy Company (SWN) Are 3 of Today’s Worst Stocks

Wednesday's rally didn't include Alcoa (AA), Esperion Therapeutics (ESPR) and Southwestern Energy (SWN), but for understandable reasons.

3 Small-Cap Stocks to Buy Before Brexit Fears Subside

All stocks will rebound sooner or later, but these three small-cap stocks will be some of the best stocks to buy.